OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Abstracts	310
PNS Abstracts 2023	58
	49
	33
	31
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study	25
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	23
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	19
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	19
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	18
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	16
	16
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	16
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	16
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	14
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	14
Ofatumumab for treating autoimmune nodopathy	14
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	13
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12
Proximal weakness involvement in the first Italian case of Charcot‐Marie‐Tooth 2CC harboring a novel frameshift variant in NEFH	12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	11
Issue Information	11
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	10
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	10
Issue Information	10

Sensory neuronopathies: A case series and literature review	9
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	9
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	9
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	9
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	9
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	8
Nerve biopsy in acquired neuropathies	8
Techniques for the standard histological and ultrastructural assessment of nerve biopsies	8
IgM anti‐MAG^± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	8
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	8
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	8
Issue Information	7
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	7
Issue Information	7
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	7
	7
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	7
Issue Information	6
	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
Issue Information	6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	6
	5
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	5
ABSTRACT	5
The autoimmune vulnerability of the node of Ranvier	5
	5
Issue Information	5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	5
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy	5
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	5
	4
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	4
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	4
2021 Peripheral Nerve Society virtual event	4
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	4
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	3
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	3
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	3
Issue Information	3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	3
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	3

Anxiety and depression in small fiber neuropathy	3
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	3